We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600111:SSEChina Northern Rare Earth (Group) High-Tech Co., Ltd. Class A Analysis

Data as of 2026-07-18 - not real-time

CN¥37.45

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading well beneath its short‑, medium‑ and long‑term moving averages, with a bearish MACD crossover and an RSI that sits deep in oversold territory. Volume has been on a downtrend, and the 30‑day price volatility is exceptionally high, suggesting heightened short‑term risk. Valuation signals: Market pricing is far above the discounted cash‑flow estimate, and the price‑to‑earnings multiple is markedly elevated, indicating that the shares are currently overvalued.
Fundamental backdrop: Despite a robust revenue growth rate, margins remain thin and free cash flow is negative, raising concerns about cash generation. The dividend yield is modest and the payout ratio is low, but sustainability is questionable given the cash‑flow profile. Debt levels are moderate and beta is modestly low, tempering market‑wide systematic risk. However, the rare‑earth sector faces heightened regulatory scrutiny and geopolitical exposure, which adds a layer of uncertainty to the company's longer‑term prospects.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price below all key moving averages
  • bearish MACD and declining volume
  • valuation far above DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • strong revenue growth offset by thin margins
  • persistent negative free cash flow
  • ongoing regulatory and geopolitical headwinds

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • strategic position in a critical rare‑earth supply chain
  • long‑term demand tailwinds for clean‑energy technologies
  • potential for valuation re‑rating if cash‑flow improves

Key Metrics & Analysis

Financial Health

Revenue Growth27.70%
Profit Margin6.07%
P/E Ratio49.3
ROE10.96%
ROA5.19%
Debt/Equity29.95
P/B Ratio5.3
Op. Cash FlowCN¥433.0M
Free Cash FlowCN¥-1013850112

Technical Analysis

TrendBearish
RSI25.9
SupportCN¥37.17
ResistanceCN¥54.15
MA 20CN¥45.53
MA 50CN¥48.72
MA 200CN¥49.43
MACDBearish
VolumeDecreasing
Fear & Greed Index87.91

Valuation

Fair ValueCN¥1.80
GradeOvervalued
TypeBlend
Dividend Yield0.35%

Risk Assessment

Beta0.51
Volatility54.85%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.